Literature DB >> 20524159

High resolution array-CGH characterization of human stem cells using a stem cell focused microarray.

Aaron M Elliott1, Kristi A Hohenstein Elliott, Anja Kammesheidt.   

Abstract

Human embryonic and induced pluripotent stem cells (ESCs, iPSCs) that are cultured for an extended period of time are susceptible to genomic instability. Chromosomal aberrations decrease the reliability and reproducibility of experiments and could deem the cells unusable for therapeutic purposes. The genetic stability of human ESCs and iPSCs is commonly monitored by karyotype analysis. However, this low-resolution technique can only identify large aneuploidies. A reliable, high-resolution technique to detect genomic aberrations at a cost comparable to karyotyping is needed to better characterize stem cell lines. We have designed a stem cell focused array-comparative genomic hybridization microarray that covers the entire genome at high resolution with increased probe coverage in over 60 stem cell associated genes and more than 195 cancer related genes. Several iPSC lines were analyzed using the focused microarray and compared with either karyotyping or a standard Agilent 44K microarray. In addition to the abnormalities detected by these platforms, the custom microarray identified several small duplications spanning stem cell and/or cancer related genes. Scientists using a stem cell focused microarray to characterize their stem cells will be aware of the structural variants present in their cells and be more confident in their experimental results.

Entities:  

Mesh:

Year:  2010        PMID: 20524159     DOI: 10.1007/s12033-010-9294-1

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  28 in total

1.  Preserving the genetic integrity of human embryonic stem cells.

Authors:  Maisam M Mitalipova; Raj R Rao; Deborah M Hoyer; Julie A Johnson; Lorraine F Meisner; Karen L Jones; Stephen Dalton; Steven L Stice
Journal:  Nat Biotechnol       Date:  2005-01       Impact factor: 54.908

2.  Gene expression signatures of seven individual human embryonic stem cell lines.

Authors:  Heli Skottman; Milla Mikkola; Karolina Lundin; Cia Olsson; Anne-Marie Strömberg; Timo Tuuri; Timo Otonkoski; Outi Hovatta; Riitta Lahesmaa
Journal:  Stem Cells       Date:  2005-08-04       Impact factor: 6.277

3.  Depletion of DNA methyltransferase 1 and/or DNA methyltransferase 3b mediates growth arrest and apoptosis in lung and esophageal cancer and malignant pleural mesothelioma cells.

Authors:  Edmund S Kassis; Ming Zhao; Julie A Hong; G Aaron Chen; Dao M Nguyen; David S Schrump
Journal:  J Thorac Cardiovasc Surg       Date:  2006-01-18       Impact factor: 5.209

4.  Recurrent chromosomal abnormalities in human embryonic stem cells.

Authors:  Claudia Spits; Ileana Mateizel; Mieke Geens; Afroditi Mertzanidou; Catherine Staessen; Yves Vandeskelde; Josiane Van der Elst; Inge Liebaers; Karen Sermon
Journal:  Nat Biotechnol       Date:  2008-11-23       Impact factor: 54.908

5.  Id proteins control growth induction in mammalian cells.

Authors:  M V Barone; R Pepperkok; F A Peverali; L Philipson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

6.  Stem cell-ness: a "magic marker" for cancer.

Authors:  John P Lahad; Gordon B Mills; Kevin R Coombes
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

7.  The transcriptome profile of human embryonic stem cells as defined by SAGE.

Authors:  Mark Richards; Siew-Peng Tan; Jee-Hian Tan; Woon-Khiong Chan; Ariff Bongso
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

8.  Id1 gene expression is up-regulated in hyperplastic and neoplastic thyroid tissue and regulates growth and differentiation in thyroid cancer cells.

Authors:  Electron Kebebew; Miao Peng; Patrick A Treseler; Orlo H Clark; Quan-Yang Duh; David Ginzinger; Richard Miner
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

Review 9.  The array CGH and its clinical applications.

Authors:  Marwan Shinawi; Sau Wai Cheung
Journal:  Drug Discov Today       Date:  2008-07-17       Impact factor: 7.851

10.  Detection of low-level mosaicism and placental mosaicism by oligonucleotide array comparative genomic hybridization.

Authors:  Stuart A Scott; Ninette Cohen; Tracy Brandt; Gokce Toruner; Robert J Desnick; Lisa Edelmann
Journal:  Genet Med       Date:  2010-02       Impact factor: 8.822

View more
  22 in total

1.  Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells.

Authors:  Seth M Taapken; Benjamin S Nisler; Michael A Newton; Tori L Sampsell-Barron; Kimberly A Leonhard; Erik M McIntire; Karen D Montgomery
Journal:  Nat Biotechnol       Date:  2011-04       Impact factor: 54.908

2.  Recurrent copy number variations in human induced pluripotent stem cells.

Authors:  Kristen Martins-Taylor; Benjamin S Nisler; Seth M Taapken; Tiwanna Compton; Leann Crandall; Karen Dyer Montgomery; Marc Lalande; Ren-He Xu
Journal:  Nat Biotechnol       Date:  2011-06-07       Impact factor: 54.908

Review 3.  Current methods and challenges in the comprehensive characterization of human pluripotent stem cells.

Authors:  Joanna S T Asprer; Uma Lakshmipathy
Journal:  Stem Cell Rev Rep       Date:  2015-04       Impact factor: 5.739

Review 4.  Genetic and epigenetic stability of human pluripotent stem cells.

Authors:  Riikka J Lund; Elisa Närvä; Riitta Lahesmaa
Journal:  Nat Rev Genet       Date:  2012-09-11       Impact factor: 53.242

5.  Derivation and long-term culture of transgene-free human induced pluripotent stem cells on synthetic substrates.

Authors:  Luis Gerardo Villa-Diaz; Jin Koo Kim; Joerg Lahann; Paul H Krebsbach
Journal:  Stem Cells Transl Med       Date:  2014-10-13       Impact factor: 6.940

6.  Comprehensive characterization of genomic instability in pluripotent stem cells and their derived neuroprogenitor cell lines.

Authors:  Nestor Luis Lopez Corrales; Kristin Mrasek; Martin Voigt; Thomas Liehr; Nadezda Kosyakova
Journal:  Appl Transl Genom       Date:  2012-08-29

7.  Footprint-free human induced pluripotent stem cells from articular cartilage with redifferentiation capacity: a first step toward a clinical-grade cell source.

Authors:  Cecilia Boreström; Stina Simonsson; Lars Enochson; Narmin Bigdeli; Camilla Brantsing; Catharina Ellerström; Johan Hyllner; Anders Lindahl
Journal:  Stem Cells Transl Med       Date:  2014-03-06       Impact factor: 6.940

Review 8.  Concise review: The evolution of human pluripotent stem cell culture: from feeder cells to synthetic coatings.

Authors:  L G Villa-Diaz; A M Ross; J Lahann; P H Krebsbach
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

Review 9.  Safety paradigm: genetic evaluation of therapeutic grade human embryonic stem cells.

Authors:  Emma Stephenson; Caroline Mackie Ogilvie; Heema Patel; Glenda Cornwell; Laureen Jacquet; Neli Kadeva; Peter Braude; Dusko Ilic
Journal:  J R Soc Interface       Date:  2010-09-08       Impact factor: 4.118

10.  A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors.

Authors:  K Tilgner; I Neganova; I Moreno-Gimeno; J Y Al-Aama; D Burks; S Yung; C Singhapol; G Saretzki; J Evans; V Gorbunova; A Gennery; S Przyborski; M Stojkovic; L Armstrong; P Jeggo; M Lako
Journal:  Cell Death Differ       Date:  2013-05-31       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.